Upm-kymmene Corporation

Sartar Therapeutics Ltd

Novartis Ag

Heikki Joensuu

Markus Nuopponen

Kari Luukko

Marjo Yliperttula

Petter Somersalo

Timo Laaksonen

Arto Merivaara

Vili-Veli Auvinen

Tiina Hakkarainen

Heli Paukkonen

Outi Monni

Anne Mäkelä

Piia-Riitta Karhemo

Raili Koivuniemi

Arto Olavi Urtti

Brian Jay Druker

Jonathan A Fletcher

Patrick Laurén

Michael C Heinrich

Elisabeth Buchdunger

George Daniel Demetri

Sandra Leta Silberman

Olli-Pekka Pulkka

Olli Kallioniemi

Renaud Capdeville

Sasa Dimitrijevic

David Tuveson

Arto Urtti

Patrick Laurën

Harri Sihto

The present disclosure provides a method for freeze-drying cells in a hydrogel comprising nanofibrillar cellulose, the method comprising providing a hydrogel comprising nanofibrillar cellulose, providing cells, combining the cells and the hydrogel comprising nanofibrillar cellulose to form a cell system, and freeze drying the cell system to obtain dried cells in a hydrogel comprising nanofibrillar cellulose. The present disclosure also provides a freeze-dried hydrogel comprising nanofibrillar cellulose and cells.

Method for freeze-drying cells in a hydrogel comprising nanofibrillar cellulose and freeze-dried cells in an aerogel comprising nanofibrillar cellulose

The present invention is related to a composition comprising a phosphodiesterase inhibitor, such as anagrelide or a salt thereof, for use in the treatment of a solid tumor, such as gastrointestinal stromal tumor (GIST) or a liposarcoma, which express phosphodiesterase 3 enzymes, in a human patient.

Compositions comprising phosphodiesterase inhibitors for use in the treatment of a solid tumor in a human patient

Growing community of inventors

Espoo, Finland

Heikki Joensuu